Trial intelligence / Profile preview

Pramipexole Long-term Efficacy in Restless Legs Syndrome

NCT00472199Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
May 2007
Primary completion
Jul 2008
Modality
Small Molecules
Countries
9
01

Overview

A Phase 4 trial of pramipexole in restless legs syndrome (RLS), sponsored by Boehringer Ingelheim. Started May 2007; status: completed.

02

Drugs

pramipexole
03

Conditions

restless legs syndrome (RLS)

Beyond the preview

Go deeper on NCT00472199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00472199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call